The Yersinia effector YopJ inhibits the innate immune response by blocking MAP kinase and NFkappaB signaling pathways. YopJ is a serine/threonine acetyltransferase which regulates signalling pathways by blocking phosphorylation [1][2]. Specifically, ...
The Yersinia effector YopJ inhibits the innate immune response by blocking MAP kinase and NFkappaB signaling pathways. YopJ is a serine/threonine acetyltransferase which regulates signalling pathways by blocking phosphorylation [1][2]. Specifically, YopJ has been shown to block phosphorylation of active site residues [3]. It has also been shown that YopJ acetyltransferase is activated by eukaryotic host cell inositol hexakisphosphate [4]. This family was previously incorrectly annotated in Pfam as being a peptidase family.
